comparemela.com

Latest Breaking News On - Ensysce biosciences company profile - Page 2 : comparemela.com

Ensysce Biosciences, Inc (NASDAQ:ENSC) Expected to Earn Q2 2023 Earnings of ($1 23) Per Share

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Free Report) – Analysts at HC Wainwright issued their Q2 2023 earnings estimates for shares of Ensysce Biosciences in a research note issued on Monday, July 3rd. HC Wainwright analyst B. Pachaiyappan forecasts that the company will post earnings of ($1.23) per share for the quarter. HC Wainwright currently has […]

Ensysce Biosciences, Inc (NASDAQ:ENSC) Short Interest Up 43 8% in May

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 113,600 shares, an increase of 43.8% from the April 30th total of 79,000 shares. Based on an average trading volume of 664,800 shares, the […]

Family Firm Inc Grows Position in Accenture plc (NYSE:ACN)

Ensysce Biosciences, Inc (NASDAQ:ENSC) Short Interest Down 92 1% in March

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Rating) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 46,000 shares, a decrease of 92.1% from the March 15th total of 580,700 shares. Based on an average trading volume of 214,300 shares, the […]

Ensysce Biosciences (NASDAQ:ENSC) Price Target Lowered to $15 00 at Lake Street Capital

Ensysce Biosciences (NASDAQ:ENSC – Get Rating) had its price objective reduced by analysts at Lake Street Capital from $96.00 to $15.00 in a research report issued to clients and investors on Wednesday, The Fly reports. Lake Street Capital’s target price would indicate a potential upside of 298.94% from the stock’s current price. Ensysce Biosciences Stock […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.